Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spesolimab Phase 2 Study in Japan
jRCT2080224942Phase 2Completed
- Start
- Nov 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 2 trial of spesolimab. Started Nov 2019; status: completed.
02
Drugs
spesolimab
Beyond the preview
Go deeper on jRCT2080224942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224942.